A systematic review analyzing the cardiovascular impact of nearly two dozen armed conflicts has identified a link between war and an increased incidence of coronary heart disease, cerebrovascular and endocrine diseases, and other risk factors among civilians.

A federal review of UNC Hospital’s pediatric cardiology unit found “no current deficiencies” in the program just two months after the New York Times published an article suggesting the unit was in “total disarray."

A study out of Brigham and Women’s Hospital in Boston has found patients insured through TRICARE, the U.S. military’s universal health insurance program, saw similar CABG outcomes regardless of their race.

Overall exposure to ionizing radiation for patients undergoing radiofrequency ablation of AFib is “acceptable” in most cases, according to research published in the American Journal of Cardiology—but obese patients are exposed to a higher dose than their normal-weight counterparts.

A study out of Israel has concluded heart attack survivors with an active sex life are better off than their less-active counterparts in the years following an MI, Reuters Health reported August 1.

In patients with both type 2 diabetes and an elevated cardiovascular risk, metformin lowers the risk of all-cause mortality but does little to protect against CV death, MI or ischemic stroke, a new evaluation of the SAVOR-TIMI 53 trial has found.

An editorial published in The Lancet August 2 scrutinized JUUL Labs’ participation in and sponsorship of e-cigarette research in the U.S., finding the vaping giant fell short in seven of eight categories designed to test ethical integrity.

Non-selective His bundle pacing is noninferior to selective HBP in patients undergoing de novo permanent pacemaker implantation for bradycardia, according to a study that revealed similar outcomes for death and HF between the two therapies.